VNDRIQ 6.1 — Governance Workflows

Executive Approval & Governance Workflows

Document, review, approve, conditionally approve, reject, renew, and periodically re-evaluate AI vendors through structured governance workflows. VNDRIQ provides governance workflow documentation to support enterprise procurement and risk management.

Governance Overview

Executive Approval Dashboard

Illustrative

247

Total Vendors Reviewed

Illustrative

132

Approved Vendors

Illustrative

48

Conditionally Approved

Illustrative

34

Under Review

Illustrative

19

Rejected

Illustrative

8

Expired Approvals

Illustrative

14

Approvals Expiring Soon

Illustrative

11

Awaiting Executive Review

Illustrative

22

Awaiting Evidence

Illustrative

17

High-Risk Vendors

Illustrative

31 days

Average Review Time

Illustrative

84%

Governance Completion Score

Illustrative

26

Decision Queue

Illustrative

43

Recent Decisions

Governance Records

Approval Records

Illustrative
VendorBusiness UnitBusiness OwnerExec SponsorStatusRisk RatingEvidenceNext Review
OpenAI EnterpriseClinical OperationsSarah ChenDr. James HollowayConditionally ApprovedModerate RiskVerified2026-11-20
Anthropic ClaudeResearch & DevelopmentMichael TorresDr. James HollowayApprovedLow RiskVerified2026-10-10
Abridge AIClinical DocumentationDr. Emily ParkDr. James HollowayUnder ReviewElevated RiskRequested2026-08-01
DeepScribeClinical DocumentationDr. Emily ParkDr. James HollowayApprovedLow RiskVerified2026-09-25
S10.AIClinical OperationsSarah ChenDr. James HollowayUnder ReviewElevated RiskPending Review2026-07-15
Pearl AIDental OperationsDr. Robert KimDr. Lisa AndersonConditionally ApprovedModerate RiskVerified2026-08-28

Record Detail

Approval Record

Illustrative

Vendor

OpenAI Enterprise

Business Unit

Clinical Operations

Business Owner

Sarah Chen

Executive Sponsor

Dr. James Holloway

Requestor

IT Procurement

Review Team

Security, Privacy, Legal

Submission Date

2026-04-15

Approval Date

2026-05-20

Expiration Date

2027-05-20

Last Review

2026-05-20

Next Review

2026-11-20

Approval Status

Conditionally Approved

Approval Category

Limited Use

Evidence Status

Verified

Risk Rating

Moderate Risk

Decision Summary

Approved for clinical documentation with BAA and human review

Governance Notes

Quarterly review required. No PHI training on customer data.

Governance Workflow

Approval Workflow Stages

Illustrative

Submitted

Vendor intake request received

Evidence Collection

Documentation requested and uploaded

Technical Review

Architecture and integration assessment

Security Review

Security controls and penetration testing

Privacy Review

Data privacy and PHI exposure evaluation

Governance Review

AI governance and model lifecycle review

Executive Review

Executive sponsor sign-off

Legal Review

Contract, BAA, and legal terms review

Conditional Approval

Approved with governance conditions

Approved

Full governance approval granted

Rejected

Vendor not approved for use

Archived

Approval record archived

Governance Conditions

Conditional Approval Types

Illustrative

No PHI

Vendor must not process protected health information

No PII

Vendor must not process personally identifiable information

Internal Use Only

Restricted to internal operational use

Human Review Required

Human oversight required for all outputs

Private Deployment Required

Must use private cloud or on-prem deployment

Limited Department Approval

Approved for specific departments only

Additional Security Controls Required

Compensating security controls required before use

Quarterly Review Required

Subject to quarterly governance re-evaluation

Vendor Documentation Pending

Awaiting vendor-provided documentation

Contract Review Required

Legal contract review required before activation

These are governance conditions, not legal conclusions. Organizations should consult legal counsel for regulatory compliance.

Cross-Functional Review

Review Assignments

Illustrative

Security

Jennifer Walsh

Completed

Privacy

Priya Sharma

Completed

Compliance

David Okafor

In Progress

Legal

Marcus Reid

In Progress

Procurement

Anna Becker

Completed

Clinical

Dr. Emily Park

Pending

IT

Tom Zhang

Completed

Executive

Dr. James Holloway

Pending

Governance

Rachel Dunn

In Progress

Audit Trail

Decision Log

Illustrative
DateReviewerDecisionReasonEvidenceNotesDocumentation
2026-05-20Jennifer Walsh (Security)Conditional ApprovalBAA verified, additional controls required for PHI accessVerifiedQuarterly review scheduledSOC 2 Report, BAA, Security Whitepaper
2026-05-15Dr. James Holloway (Executive)ApprovedAll governance stages completed successfullyVerifiedFull approval for research workflowsComplete Evidence Package
2026-05-10Marcus Reid (Legal)Conditional ApprovalContract terms require additional reviewVerifiedData processing addendum under negotiationDPA, BAA Draft
2026-04-28Priya Sharma (Privacy)Under ReviewPHI exposure assessment in progressRequestedAwaiting data flow diagramData Flow Diagram (Pending)
2026-04-15Jennifer Walsh (Security)SubmittedInitial vendor intake receivedPending ReviewEvidence collection initiatedVendor Intake Form
2026-03-25Dr. Emily Park (Clinical)ApprovedClinical workflow validation completeVerifiedHuman review protocol establishedClinical Validation Report
2026-03-10Marcus Reid (Legal)Conditional ApprovalBAA executed with data retention limitationsVerified2-year data retention cap enforcedExecuted BAA, Retention Policy
2026-02-28Dr. Lisa Anderson (Executive)Conditional ApprovalFDA cleared with clinical oversight requirementVerifiedDiagnostic outputs require dentist reviewFDA 510(k), Clinical Evidence

Risk Governance

Risk Acceptance

Illustrative

Residual Risk

Moderate Risk

Executive Acceptance

Dr. James Holloway, Chief Medical Officer

Review Date

2026-05-20

Expiration

2026-11-20

Business Justification

Clinical documentation automation improves physician efficiency and reduces after-hours documentation burden. No viable lower-risk alternative meets workflow requirements.

Compensating Controls

BAA executed, human review of all AI outputs, quarterly security assessment, restricted PHI access, audit logging enabled, private deployment configuration

Approval Lifecycle

Renewal Tracking

Illustrative
VendorApproval TypeRenewal StatusNext ReviewDays Remaining
OpenAI EnterpriseConditionally ApprovedUpcoming Renewal2026-11-20159 days
Anthropic ClaudeApprovedCurrent2026-10-1088 days
DeepScribeApprovedCurrent2026-09-2573 days
Pearl AIConditionally ApprovedUpcoming Renewal2026-08-2845 days
S10.AIResearch OnlyScheduled2026-07-151 days
Abridge AIPilot OnlyScheduled2026-08-0118 days
Nuance DAXRetiredExpired2026-06-0143 days overdue
Suki AILimited UseOverdue2026-06-1529 days overdue

Evidence Management

Documentation Checklist

Illustrative

Security Whitepaper

Available

SOC Report

Verified

ISO Evidence

Available

Privacy Policy

Verified

Terms of Service

Verified

BAA

Verified

Architecture Overview

Available

Subprocessor List

Pending

AI Governance Documentation

Available

Responsible AI Documentation

Requested

Incident Response Plan

Available

Business Continuity Plan

Pending

Governance FAQ

Executive Approval & Governance

What is an AI vendor approval workflow?▼

An AI vendor approval workflow is a structured governance process that organizations use to evaluate, review, and approve AI vendors before deployment. It typically includes stages such as evidence collection, technical review, security review, privacy review, governance review, executive review, and legal review. The workflow documents decisions, conditions, risk acceptance, and renewal schedules to ensure ongoing governance accountability.

Who should approve enterprise AI vendors?▼

Enterprise AI vendor approval should involve a cross-functional review team including security, privacy, compliance, legal, procurement, clinical, IT, governance, and executive stakeholders. Each role evaluates the vendor from their domain perspective. Final approval typically requires executive sponsor sign-off, with legal review ensuring contractual protections such as BAAs and data processing agreements are in place.

What is conditional approval for AI vendors?▼

Conditional approval means a vendor is approved for use with specific governance conditions attached. Common conditions include no PHI processing, human review of AI outputs, private deployment requirements, limited department approval, additional security controls, quarterly review requirements, or pending vendor documentation. Conditional approvals are governance conditions, not legal conclusions, and require ongoing monitoring.

When should AI vendors be re-reviewed?▼

AI vendors should be re-reviewed on a defined schedule, typically monthly, quarterly, semi-annually, or annually depending on risk level and approval type. Re-review is also triggered by significant changes such as security incidents, policy updates, subprocessor changes, model version updates, or contract renewals. High-risk vendors and conditionally approved vendors typically require more frequent review.

How should governance teams document AI vendor decisions?▼

Governance teams should maintain a structured decision log that records the date, reviewer, decision, reasoning, evidence status, governance notes, and supporting documentation for each stage of the approval workflow. Documentation should include the approval record, risk acceptance details, conditional approval conditions, review assignments, evidence checklist, and renewal schedule. This creates an auditable governance trail for regulatory accountability.

Governance Disclaimers

  • • VNDRIQ provides governance workflow documentation to support enterprise procurement and risk management.
  • • Approval decisions remain the responsibility of each organization.
  • • VNDRIQ does not provide legal advice or regulatory approval.
  • • Illustrative workflow examples are for demonstration purposes.